Trials / Unknown
UnknownNCT05259332
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas and Immunohistochemical Applications
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine by a transcriptomic approach new prognostic and predictive markers in atypical meningiomas (WHO grade II). Retrospective observational study, on a cohort of 85 atypical meningiomas. Transcriptomic study first, on cryopreserved tumor samples. Then identify, thanks to the transcriptomic study, prognostic and predictive factors (study of the link between the quantity of certain RNA transcripts and progression-free survival). Finally, set up immunohistochemical applications, which can be used routinely by the pathologist.
Conditions
Timeline
- Start date
- 2022-02-25
- Primary completion
- 2022-04-01
- Completion
- 2023-10-31
- First posted
- 2022-02-28
- Last updated
- 2022-02-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05259332. Inclusion in this directory is not an endorsement.